Crossref

1. Egg consumption and risk of non-alcoholic fatty liver disease

- Zeinab Mokhtari

- Hossein Poustchi

- Tannaz Eslamparast

- Azita Hekmatdoost

2. The hepatoprotective effect of ginger

- Yi-Shin Huang

3. Hepatoprotective and Renoprotective Properties of Lovastatin-Loaded Ginger and Garlic Oil Nanoemulsomes: Insights into Serum Biological Parameters

- Syed Ali Faran

- Sajid Asghar

- Syed Haroon Khalid

- Ikram Ullah Khan

- Muhammad Asif

- Ikrima Khalid

- Umar Farooq Gohar

- Tanveer Hussain

4. Assessing the Effects of Ginger Extract on Polyphenol Profiles and the Subsequent Impact on the Fecal Microbiota by Simulating Digestion and Fermentation In Vitro

- Jing Wang

- Yong Chen

- Xiaosong Hu

- Fengqin Feng

- Luyun Cai

- Fang Chen

5. Ginger: Panacea or Consumer’s Hype?

- Susana Santos Braga

6. Evaluation of the effects of alcoholic extract of ginger on renal cytotoxicity of silver nanoparticles: a Mus musculus model

- Nasrin Kazemipour

- Shabnam Moradi

- Masood Sepehrimanesh

- Saeed Nazifi

7. Effects of Some Food Components on Non-Alcoholic Fatty Liver Disease Severity: Results from a Cross-Sectional Study

- Antonella Mirizzi

- Isabella Franco

- Carla Maria Leone

- Caterina Bonfiglio

- Raffaele Cozzolongo

- Maria Notarnicola

- Vito Giannuzzi

- Valeria Tutino

- Valentina De Nunzio

- Irene Bruno

- Claudia Buongiorno

- Angelo Campanella

- Valentina Deflorio

- Annamaria Pascale

- Filippo Procino

- Paolo Sorino

- Alberto Rubén Osella

8. A systematic review of the anti‐obesity and weight lowering effect of ginger (Zingiber officinale Roscoe) and its mechanisms of action

- Vahideh Ebrahimzadeh Attari

- Aida Malek Mahdavi

- Zeinab Javadivala

- Sepideh Mahluji

- Sepideh Zununi Vahed

- Alireza Ostadrahimi

9. Investigation of the Synergistic Effect of Brown Sugar, Longan, Ginger, and Jujube (Brown Sugar Longan Ginger Tea) on Antioxidation and Anti‐Inflammation in In Vitro Models

- Ping Lin

- Kai-Wen Kan

- Jia-Haur Chen

- Yung-Kai Lin

- Yung-Hao Lin

- Yung-Hsiang Lin

- Wei-Chun Hu

- Chi-Fu Chiang

- Chen-Meng Kuan

- Antonella Fioravanti

10. Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis

- Oluyemi Komolafe

- Elena Buzzetti

- Audrey Linden

- Lawrence MJ Best

- Angela M Madden

- Danielle Roberts

- Thomas JG Chase

- Dominic Fritche

- Suzanne C Freeman

- Nicola J Cooper

- Alex J Sutton

- Elisabeth Jane Milne

- Kathy Wright

- Chavdar S Pavlov

- Brian R Davidson

- Emmanuel Tsochatzis

- Kurinchi Selvan Gurusamy

11. Exploring Therapeutic Potential of Ginger: Preclinical and Clinical Review

- Anuradha D. Otari

- Rupali A. Patil

12. The effects of Zataria multiflora Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: A randomized double-blind placebo-controlled clinical trial

- Nasrindokht Zamani

- Mesbah Shams

- Majid Nimrouzi

- Mohammad Mehdi Zarshenas

- Amin Abolhasani Foroughi

- Ebrahim Fallahzadeh Abarghooei

- Mohammad Reza Fattahi

13. Green Tea in Non-Alcoholic Fatty Liver Disease: A Double Blind Randomized Clinical Trial

- Seyed Mohammad Tabatabaee

- Seyed Moayed Alavian

- Leila Ghalichi

- Seyed Mohammad Miryounesi

- Kazem Mousavizadeh

- Shima Jazayeri

- Mohammad Reza Vafa

14. Ginger and avocado as nutraceuticals for obesity and its comorbidities

- Natalia dos Santos Tramontin

- Thais F. Luciano

- Scherolin de Oliveira Marques

- Claudio T. de Souza

- Alexandre P. Muller

15. Effect of ginger (Zingiber officinale) on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials

- Mojgan Morvaridzadeh

- Siavash Fazelian

- Shahram Agah

- Maryam Khazdouz

- Mehran Rahimlou

- Fahimeh Agh

- Eric Potter

- Shilan Heshmati

- Javad Heshmati

16. Effect of oral and topical ginger on primary dysmenorrhoea: a systematic review

- Soheila Nazarpour

- Masoumeh Simbar

17. Potential Role of Ginger (Zingiber officinale Roscoe) in the Prevention of Neurodegenerative Diseases

- Raúl Arcusa

- Débora Villaño

- Javier Marhuenda

- Miguel Cano

- Begoña Cerdà

- Pilar Zafrilla

18. Nigella sativa and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Results from a randomized, double-blind, placebo-controlled, clinical trial

- Mina Darand

- Zahra Darabi

- Zahra Yari

- Saeedeh Saadati

- Mehdi Hedayati

- Ahmad Khoncheh

- Behnam Hosseini-Ahangar

- Seyed moayyed Alavian

- Azita Hekmatdoost

19. A subcritical water extract of soil grown Zingiber officinale Roscoe: Comparative analysis of antioxidant and anti-inflammatory effects and evaluation of bioactive metabolites

- Azraul Mumtazah Razak

- Siti Nor Asyikin Zakaria

- Nur Fathiah Abdul Sani

- Nazirah Ab Rani

- Nur Haleeda Hakimi

- Mazlina Mohd Said

- Jen Kit Tan

- Han Kwang Gan

- Mariam Firdhaus Mad Nordin

- Suzana Makpol

20. Curcumin's antioxidant effects on inflammatory diseases

- Halime Selen

- Veysel Çomaklı

21.

22. Beneficial effects of ginger Zingiber officinale Roscoe on obesity and metabolic syndrome: a review

- Jing Wang

- Weixin Ke

- Rui Bao

- Xiaosong Hu

- Fang Chen

23. Zingiber officinale formulation reduces hepatic injury and weight gain in rats fed an unhealthy diet

- DALILA T. LEAL

- GLEIDE G. FONTES

- JULIA K.D. VILLA

- RODRIGO B. FREITAS

- MATEUS G. CAMPOS

- CAMILO A. CARVALHO

- VIRGINIA R. PIZZIOLO

- MARISA A.N. DIAZ

24.

25. The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review

- Kiana Mohammadian

- Fatemeh Fakhar

- Shayan Keramat

- Agata Stanek

26. Effect of Dietary Intervention, with or without Cointerventions, on Inflammatory Markers in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

- Renate L. Hall

- Elena S. George

- Audrey C. Tierney

- Anjana J. Reddy

27. Gegen Qinlian Decoction Attenuates High‐Fat Diet‐Induced Steatohepatitis in Rats via Gut Microbiota

- Yi Guo

- Pang-hua Ding

- Li-juan Liu

- Lei Shi

- Tang-you Mao

- Jun-xiang Li

- Yun-liang Wang

- Flávio Reis

28. The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: A randomized, placebo-controlled, clinical trial

- Khadijeh Abhari

- Saeede Saadati

- Zahra Yari

- Hedayat Hosseini

- Mehdi Hedayati

- Shahabeddin Abhari

- Seyyed Moayyed Alavian

- Azita Hekmatdoost

29. Hepatic steatosis integrated approach: nutritional guidelines and joined nutraceutical administration

- Beniamino PALMIERI

- Veronica CORAZZARI

- Diana G. PANARIELLO BRASILE

- Vincenzo SANGIOVANNI

- Maria VADALÀ

30. Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease

- Christine C Hsu

- Erik Ness

- Kris V Kowdley

31. The effects of hydroalcoholic extract of spinach on prevention and treatment of some metabolic and histologic features in a rat model of nonalcoholic fatty liver disease

- Ali Amirinejad

- Azita Hekmatdoost

- Abdolali Ebrahimi

- Fatemeh Ranjbaran

- Farzad Shidfar

32. The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: A randomized, double‐blind, placebo‐controlled clinical trial

- Mina Darand

- Zahra Darabi

- Zahra Yari

- Mehdi Hedayati

- Mohammad Amin Shahrbaf

- Ahmad Khoncheh

- Behnam Hosseini‐Ahangar

- Seyed Moayyed Alavian

- Azita Hekmatdoost

33. Therapeutic effects of curcumin supplementation on liver enzymes of nonalcoholic fatty liver disease patients: A systematic review and meta‐analysis of randomized clinical trials

- Armin Ebrahimzadeh

- Anahita Ebrahimzadeh

- Sara Fooladshekan

- Shokouh Mohseni

- Abbas Mohtashamian

- Siavash Babajafari

- Zahra Sohrabi

34. The effect of ginger supplementation on serum C-reactive protein, lipid profile and glycaemia: a systematic review and meta-analysis

- Mohsen Mazidi

- Hong-Kai Gao

- Peyman Rezaie

- Gordon A. Ferns

35. The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial

- Zahra Yari

- Makan Cheraghpour

- Seyed Moayed Alavian

- Mehdi Hedayati

- Hassan Eini-Zinab

- Azita Hekmatdoost

36. Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD

- Brandon J. Perumpail

- Andrew A. Li

- Umair Iqbal

- Sandy Sallam

- Neha D. Shah

- Waiyee Kwong

- George Cholankeril

- Donghee Kim

- Aijaz Ahmed

37. Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta‐analysis of randomized controlled trials

- Reza Goodarzi

- Kamran Sabzian

- Farideh Shishehbor

- Anahita Mansoori

38. The effect of 6-gingerol on biochemical and histological parameters in cholesterol-induced nonalcoholic fatty liver disease in NMRI mice

- Asal Sarrafan

- Maryam Ghobeh

- Parichehreh Yaghmaei

39. What are the main areas of focus to prevent or treat non‐alcoholic fatty liver disease?

- Asieh Mansour

- Azita Hekmatdoost

- Parvin Mirmiran

40. Legume intake and risk of nonalcoholic fatty liver disease

- Alireza Bahrami

- Farshad Teymoori

- Tannaz Eslamparast

- Golbon Sohrab

- Ehsan Hejazi

- Hossein Poustchi

- Azita Hekmatdoost

41. Effect of big eye tuna (Thunnusobesus) head soup with different colloidal particle size on TG and TC deposition in FFA‐exposed HepG2 cells

- Jing Zhang

- Liu Lin

- Ningping Tao

- Zheqing Zhu

- Xichang Wang

- Mingfu Wang

42. Red and Processed Meat Intake in Relation to Non-Alcoholic Fatty Liver Disease Risk: Results from a Case-Control Study

- Fatemeh Rahimi-Sakak

- Mahsa Maroofi

- Hadi Emamat

- Azita Hekmatdoost

43. Best Practices, Resources and Innovations: A Mechanistic Review of Nausea and Vomiting Management Options in Cirrhosis

- Claudio Roberto Tombazzi

- Sara F. Martin

44. Antihyperglycemic Effect of Fenugreek and Ginger in Patients with Type 2 Diabetes: A Double-Blind, Placebo-controlled Study

- Mohamed A. Elsaadany

- Hussah M. AlTwejry

- Rwabi A. Zabran

- Sara A. AlShuraim

- Wala'a A. AlShaia

- Omar I. Abuzaid

- Waleed I. AlBaker

45. Multiple molecular targets in the liver, adipose tissue and skeletal muscle in ginger-elicited amelioration of nonalcoholic fatty liver disease

- Chunxia Wang

- Robert Batey

- Johji Yamahara

- Yuhao Li

46. Effect of dietary intervention, with or without co-interventions, on inflammatory markers in patients with nonalcoholic fatty liver disease: a systematic literature review

- Anjana J Reddy

- Elena S George

- Stuart K Roberts

- Audrey C Tierney

47. Evaluating Bioactive-Substance-Based Interventions for Adults with MASLD: Results from a Systematic Scoping Review

- Deepa Handu

- Kim Stote

- Tami Piemonte

48. Spices in a High-Saturated-Fat, High-Carbohydrate Meal Reduce Postprandial Proinflammatory Cytokine Secretion in Men with Overweight or Obesity: A 3-Period, Crossover, Randomized Controlled Trial

- Ester S Oh

- Kristina S Petersen

- Penny M Kris-Etherton

- Connie J Rogers

49. Fructose Consumption is Associated with Non-Alcoholic Fatty Liver Disease Risk: A Case-Control Study from Iran

- Mina Darand

- Zahra Darabi

- Zahra Yari

- Azita Hekmatdoost

50. Bentong ginger oleoresin mitigates liver injury and modulates gut microbiota in mouse with nonalcoholic fatty liver disease induced by high‐fat diet

- Kunli Wang

- Bei Li

- Rao Fu

- Zefang Jiang

- Xin Wen

- Yuanying Ni

51. Therapeutic potentials of ginger for treatment of Multiple sclerosis: A review with emphasis on its immunomodulatory, anti-inflammatory and anti-oxidative properties

- Abdollah Jafarzadeh

- Maryam Nemati

52. Suppressive Effect of Yuzu (<i>Citrus junos</i>) Peel Extract on Fatty Liver Steatosis Induced by a High-sucrose Diet in Rats

- Ayako Suzuki

- Shiori Miyajima

- Satoshi Mochizuki

- Miki Umeki

- Kumiko Sakai

- Mami Koya

- Hiroaki Oda

- Kaoru Nobuoka

- Yuichi Ishikawa

53. Effects of one-year supplementation with Phyllanthus niruri on fibrosis score and metabolic markers in patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial

- Muhammad Radzi Abu Hassan

- Rosaida Hj Md Said

- Zalwani Zainuddin

- Haniza Omar

- Siti Maisarah Md Ali

- Siti Aishah Aris

- Huan-Keat Chan

54. Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease

- Daniela Ciobârcă

- Adriana Florinela Cătoi

- Laura Gavrilaș

- Roxana Banc

- Doina Miere

- Lorena Filip

55. Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial

- Saeede Saadati

- Amir Sadeghi

- Asieh Mansour

- Zahra Yari

- Hossein Poustchi

- Mehdi Hedayati

- Behzad Hatami

- Azita Hekmatdoost

56. Ginger extract controls mTOR-SREBP1-ER stress-mitochondria dysfunction through AMPK activation in obesity model

- Geum-Hwa Lee

- Cheng Peng

- Soon-Yeon Jeong

- Seon-Ah Park

- Hwa-Young Lee

- The-Hiep Hoang

- Junghyun Kim

- Han-Jung Chae

57. Ginger in gastrointestinal disorders: A systematic review of clinical trials

- Mehrnaz Nikkhah Bodagh

- Iradj Maleki

- Azita Hekmatdoost

58. The effects of ginger supplementation on markers of inflammatory and oxidative stress: A systematic review and meta‐analysis of clinical trials

- Mohammad Jalali

- Marzieh Mahmoodi

- Seyedeh Parisa Moosavian

- Ronak Jalali

- Gordon Ferns

- Abdolhamid Mosallanezhad

- Mohammad Hadi Imanieh

- Zahra Mosallanezhad

59. A systematic review and meta‐analysis of preclinical and clinical studies on the efficacy of ginger for the treatment of fatty liver disease

- Mehnoosh Samadi

- Mehdi Moradinazar

- Tina Khosravy

- Davood Soleimani

- Parvin Jahangiri

- Negin Kamari

60. Therapeutic health effects of ginger (Zingiber officinale): updated narrative review exploring the mechanisms of action

- Megan Crichton

- Skye Marshall

- Wolfgang Marx

- Elizabeth Isenring

- Anna Lohning

61. Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial

- Makan Cheraghpour

- Hossein Imani

- Shahrzad Ommi

- Seyed Moayed Alavian

- Elahe Karimi‐Shahrbabak

- Mehdi Hedayati

- Zahra Yari

- Azita Hekmatdoost

62. NAFLD and nutraceuticals: a review of completed phase III and IV clinical trials

- Omar E. Hegazi

- Samer O. Alalalmeh

- Ghala Rashid Humaid Alnuaimi

- Moyad Shahwan

- Ammar Abdulrahman Jairoun

- Nasser M. Alorfi

- Shaker A. Majrashi

- Mustfa Faisal Alkhanani

- Abdullah Alkhattabi

- Mansour M. Alourfi

- Faris A. Alsolami

- Saeed Alsharif

- Hatim Alshahrani

63. The efficacy of Zingiber officinale on dyslipidaemia, blood pressure, and inflammation as cardiovascular risk factors: A systematic review

- Chelsea Courtney Daniels

- Zaiyaan Isaacs

- Renata Finelli

- Kristian Leisegang

64. The Effects of Ginger ( Zingiber Officinale Roscoe) on Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blinded Placebo-Controlled Clinical Trial

- Parissa Sadat Ghoreishi

- Mesbah Shams

- Majid Nimrouzi

- Mohammad M. Zarshenas

- Kamran Bagheri Lankarani

- Ebrahim Fallahzadeh Abarghooei

- Mozaffar Talebzadeh

- Mohammad Hashem Hashempur

65. Ginger (Zingiber officinale Roscoe; Family: Zingiberaceae) in Non-Alcoholic Fatty Liver Disease: Review on the Existing Scientific Evidence and Way Forward

- Pankaj Prabhakar

- Vijay Marakala

- Dhanya Sacheendran

- Thomas George

- Rhea Katherine D'souza

- Princy Louis Palatty

- Manjeshwar Shrinath Baliga

66.

67.